Literature DB >> 28325189

Surveillance for Gastric Cancer.

Shachar Laks1, Michael O Meyers1, Hong Jin Kim2.   

Abstract

This article discusses the current National Comprehensive Cancer Network guidelines and other available Western and Eastern guidelines for the surveillance of gastric cancer following surgical resection. It reviews the literature assessing the utility of intensive surveillance strategies for gastric cancer, which fails to show an improvement in survival. The unique issues relating to follow-up of early gastric cancer and after endoscopic resection of early gastric cancer are discussed. This article also reviews the available modalities for follow-up. In addition, it briefly discusses the advancements in treatment of recurrent and metastatic disease and the implications for gastric cancer survival and surveillance strategies.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adenocarcinoma; Early gastric cancer; Follow-up studies; Gastrectomy; Gastric cancer; Stomach neoplasms; Surveillance

Mesh:

Year:  2017        PMID: 28325189     DOI: 10.1016/j.suc.2016.11.007

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  6 in total

1.  SEOM clinical guideline for the diagnosis and treatment of gastric cancer (GC) and gastroesophageal junction adenocarcinoma (GEJA) (2019).

Authors:  M Martín-Richard; A Carmona-Bayonas; Ana B Custodio; J Gallego; P Jiménez-Fonseca; J J Reina; P Richart; F Rivera; M Alsina; J Sastre
Journal:  Clin Transl Oncol       Date:  2020-01-27       Impact factor: 3.405

2.  DNA aptamers from whole-serum SELEX as new diagnostic agents against gastric cancer.

Authors:  Yue Zheng; Yunwang Zhao; Ya Di; Chenlin Xiu; Lei He; Shiqi Liao; Dongdong Li; Baihai Huang
Journal:  RSC Adv       Date:  2019-01-09       Impact factor: 4.036

3.  Gastric Cancer Peritoneal Carcinomatosis Risk Score.

Authors:  Liang Ji; Matthew J Selleck; John W Morgan; Jane Xu; Blake D Babcock; David Shavlik; Nathan R Wall; William H Langridge; Sharon S Lum; Carlos A Garberoglio; Mark E Reeves; Naveenraj Solomon; Jukes P Namm; Maheswari Senthil
Journal:  Ann Surg Oncol       Date:  2019-07-25       Impact factor: 5.344

4.  Nomogram for predicting the survival of gastric adenocarcinoma patients who receive surgery and chemotherapy.

Authors:  Chao-Yang Wang; Jin Yang; Hao Zi; Zhong-Li Zheng; Bing-Hui Li; Yang Wang; Zheng Ge; Guang-Xu Jian; Jun Lyu; Xiao-Dong Li; Xue-Qun Ren
Journal:  BMC Cancer       Date:  2020-01-06       Impact factor: 4.430

5.  UKCGG Consensus Group guidelines for the management of patients with constitutional TP53 pathogenic variants.

Authors:  Helen Hanson; Angela F Brady; Gillian Crawford; Rosalind A Eeles; Sarah Gibson; Mette Jorgensen; Louise Izatt; Aslam Sohaib; Marc Tischkowitz; D Gareth Evans
Journal:  J Med Genet       Date:  2020-06-22       Impact factor: 5.941

6.  CircPDZD8 promotes gastric cancer progression by regulating CHD9 via sponging miR-197-5p.

Authors:  Tianfang Xia; Zhenguo Pan; Jie Zhang
Journal:  Aging (Albany NY)       Date:  2020-10-13       Impact factor: 5.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.